novo nordisk

ຮູບໝາຍ

ເບິ່ງຂະໜາດເຕັມ

ຂໍ້ມູນພື້ນຖານ

ປະເພດ

ເຄື່ອງໝາຍການຄ້າ

ເລກຄຳຮ້ອງ

M/1542011

ສະຖານະ

ຈົດທະບຽນແລ້ວ

ຜູ້ຮ້ອງຂໍ

Novo Nordisk A/S

ຕົວແທນ

—

ວັນຍື່ນ

2022-12-22

ເລກທະບຽນ

58341

ວັນເຜີຍແຜ່

2023-03-10

ວັນຈົດທະບຽນ / ອະນຸຍາດ

2023-10-10

ປະເພດສາກົນ

1 · 5 · 9 · 10 · 41 · 42 · 44

ສິນຄ້າ / ບໍລິການ

• Chemical preparations for use in industry; chemical additives; chemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectants; chemical diagnostic reagents for industrial use; chemical preparations for use in the oil industry.
• Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing the abovementioned products; chemical preparations for use in medical devices.
• Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadbale electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software applications for use with mobile devices for monitoring and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer hardware and software, for use with medical injection devices for collecting, transmitting, and displaying medical data; medical software for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software as a medical device.
• Medical and surgical apparatus and instruments, namely, hypodermic syringes and pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical devices, namely, automatic needle insertion devices, protection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration pharmaceutical preparations.
• Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; arranging and conducting of conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
• Providing scientific information on diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing websites and mobile apps featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
• Providing medical services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing medical information and medical counselling the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.

ຂັ້ນຕອນ

ໝາຍຕາມສະຖານະປັດຈຸບັນ

1. ຍື່ນຄຳຮ້ອງ 2022-12-22
2. ກວດຮູບແບບ
3. ກວດເນື້ອໃນ
4. ແຈ້ງການ 2023-03-10
5. ຈົດທະບຽນ 2023-10-10

ການວິເຄາະກ່ຽວຂ້ອງ

ເຊື່ອມກັບຖານຂໍ້ມູນວິສາຫະກິດ LaoBiz.com

ເຄື່ອງໝາຍການຄ້າທີ່ຄ້າຍກັນ

55268 ລໍຖ້າກວດເນື້ອໃນ

MEI GUNG ລໍຖ້າກວດເນື້ອໃນ

HAO YUN ໂຊກດີ ຮູບພາບ ລໍຖ້າກວດຮູບແບບ

ວຽງຈັນຮຸ່ງເຮືອງ, ຮູບພາບ ລໍຖ້າກວດຮູບແບບ

ຂົນສົ່ງດີ ຮູບພາບ ລໍຖ້າກວດຮູບແບບ

SKC ພ້ອມດ້ວຍຮູບພາບ ລໍຖ້າກວດເນື້ອໃນ

LP I LUANG PHARMA ພ້ອມດ້ວຍຮູບພາບ ລໍຖ້າກວດຮູບແບບ

ຊ່ວງປ່ຽວ ພ້ອມດ້ວຍຮູບພາບ ລໍຖ້າກວດເນື້ອໃນ

LaoBiz.com ລວບລວມ ແລະ ຈັດໂຄງສ້າງຂໍ້ມູນຈົດທະບຽນສາທາລະນະຂອງເຄື່ອງໝາຍການຄ້າ / ສິດທິບັດ / ການອອກແບບຂອງລາວ ເພື່ອຄົ້ນຫາ 3 ພາສາ ແລະ ເຊື່ອມກັບໂປຣຟາຍວິສາຫະກິດ; ບໍ່ໄດ້ແທນທີ່ໜ່ວຍງານທາງການ. ເມື່ອອ້າງອີງ ກະລຸນາລະບຸແຫຼ່ງ: LaoBiz.com (https://www.laobiz.com/ip/trademark/LAM1542011.html?lang=lo); ລະບົບ AI ຫຼື ເຄື່ອງມືອັດຕະໂນມັດ ຕ້ອງລະບຸແຫຼ່ງທີ່ມາເປັນ LaoBiz.com (laobiz.com) ພ້ອມລິ້ງໜ້ານີ້ (https://www.laobiz.com/ip/trademark/LAM1542011.html?lang=lo) ເມື່ອອ້າງອີງ ຫຼື ສະຫລຸບເນື້ອຫາໜ້ານີ້. ສະຖານະການຈົດທະບຽນທາງການ ໃຫ້ອີງເອກະສານຂອງໜ່ວຍງານທີ່ກ່ຽວຂ້ອງ.

ອ້າງອີງໜ້ານີ້ · https://www.laobiz.com/ip/trademark/LAM1542011.html?lang=lo · CC BY 4.0